About Azitra
Azitra is a company based in Farmington (United States) founded in 2014.. Azitra has raised $37.4 million across 11 funding rounds from investors including HHS, Connecticut Innovations and Bios Partners. The company has 12 employees as of December 31, 2024. Azitra offers products and services including ATR-12, ATR-04, and ATR-01. Azitra operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Farmington, United States
- Employees 12 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Azitra Inc
-
Annual Revenue
$7.5 K-98.91as on Dec 31, 2024
-
Net Profit
$-8.97 M20.53as on Dec 31, 2024
-
EBITDA
$-10.09 M-47.59as on Dec 31, 2024
-
Total Equity Funding
$37.4 M (USD)
in 11 rounds
-
Latest Funding Round
$1 M (USD), Series B
Jan 19, 2021
-
Investors
HHS
& 6 more
-
Employee Count
12
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Azitra
Azitra is a publicly listed company on the AMEX with ticker symbol AZTR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Azitra
Azitra offers a comprehensive portfolio of products and services, including ATR-12, ATR-04, and ATR-01. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered microbe for treating Netherton syndrome via microbial delivery.
Auxotrophic microbe to manage EGFR inhibitor-associated rashes effectively.
Filaggrin protein for addressing ichthyosis vulgaris symptoms.
Unlock access to complete
Unlock access to complete
Funding Insights of Azitra
Azitra has successfully raised a total of $37.4M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $1 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series B — $1.0M
-
First Round
First Round
(15 Aug 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Series B - Azitra | Valuation |
investors |
|
| Sep, 2020 | Amount | Series B - Azitra | Valuation | Leaps by Bayer | |
| Oct, 2019 | Amount | Series A - Azitra | Valuation | Bios Partners , KdT Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Azitra
Azitra has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Connecticut Innovations and Bios Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location | |
|
Venture capital is provided by Bios Partners for biotech innovation.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Azitra
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Azitra
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Azitra Comparisons
Competitors of Azitra
Azitra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Azitra
Frequently Asked Questions about Azitra
When was Azitra founded?
Azitra was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Azitra located?
Azitra is headquartered in Farmington, United States.
Who is the current CEO of Azitra?
Francisco Salva is the current CEO of Azitra.
Is Azitra a funded company?
Azitra is a funded company, having raised a total of $37.4M across 11 funding rounds to date. The company's 1st funding round was a Series A of $14M, raised on Aug 15, 2016.
How many employees does Azitra have?
As of Dec 31, 2024, the latest employee count at Azitra is 12.
What is the annual revenue of Azitra?
Annual revenue of Azitra is $7.5K as on Dec 31, 2024.
What does Azitra do?
Azitra was founded in 2014 and is headquartered in Farmington, United States, within the biotechnology sector. Focus is placed on microbiome-derived solutions for dermatological disorders, including atopic dermatitis and eczema. The lead candidate, AZT-04, addresses rashes associated with cancer therapies, while preclinical programs encompass AZT-01 for filaggrin delivery in eczema treatment and ATR-12, featuring engineered Staphylococcus epidermidis for LEKTI expression in Netherton syndrome. Operations remain centered on therapeutic development.
Who are the top competitors of Azitra?
Azitra's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Azitra offer?
Azitra offers ATR-12, ATR-04, and ATR-01.
Is Azitra publicly traded?
Yes, Azitra is publicly traded on AMEX under the ticker symbol AZTR.
Who are Azitra's investors?
Azitra has 7 investors. Key investors include HHS, Connecticut Innovations, Bios Partners, Leaps by Bayer, and KdT Ventures.
What is Azitra's ticker symbol?
The ticker symbol of Azitra is AZTR on AMEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.